Clinical trial
Exploratory Study to Investigate the Association Between the Onset of Disseminated Intravascular Coagulation (DIC) and Disease Progression With Different Biomarker Candidates as Well as Standard Clinical and Demographic Parameters in Adult Patients With Sepsis
NCT06986798 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Study to Investigate the Association Between the Onset of Disseminated Intravascular Coagulation (DIC) and Disease Progression With Different Biomarker Candidates as Well as Standard Clinical and Demographic Parameters in Adult Patients With Sepsis
- Lead sponsor
- Bayer
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 29, 2025
- Completion date
- May 6, 2026
- Enrollment
- 150 (actual)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.
sepsis, sepsis associated dic